Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform

13 Pages Posted: 16 Oct 2012  

Marc A. Rodwin

Suffolk University Law School; Harvard University - Edmond J. Safra Center for Ethics

Date Written: October 16, 2012

Abstract

When physicians’ conflicts of interest arise from ties with drug firms, we should shift our focus to the pharmaceutical industry and improper dependencies that cause institutional corruption. This article analyzes eight forms of improper dependencies on pharma and proposes reforms.

Suggested Citation

Rodwin, Marc A., Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform (October 16, 2012). Journal of Law, Medicine and Ethics, Vol. 40, p. 511, 2012; Suffolk University Law School Research Paper No. 12-40. Available at SSRN: https://ssrn.com/abstract=2162597

Marc A. Rodwin (Contact Author)

Suffolk University Law School ( email )

120 Tremont Street
Boston, MA 02108-4977
United States
617-573-8354 (Phone)
617-305-3087 (Fax)

HOME PAGE: http://www.law.suffolk.edu/faculty/directories/faculty.cfm?InstructorID=48

Harvard University - Edmond J. Safra Center for Ethics ( email )

124 Mount Auburn Street
Suite 520N
Cambridge, MA 02138
United States

Paper statistics

Downloads
283
Rank
88,589
Abstract Views
1,136